You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SINE

Showing 1 - 25 of 284
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pruritus, Chronic Pruritus, Itch Trial in Brest (Blood samples, skin swab sample, skin biopsy sample)

Not yet recruiting
  • Pruritus
  • +2 more
  • Blood samples
  • +4 more
  • Brest, France
    Service de dermatologie, CHRU BREST
Dec 23, 2022

Atrial Fibrillation Trial in Tbilisi (Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System)

Recruiting
  • Atrial Fibrillation
  • Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation System
  • Tbilisi, Georgia
    Israeli-Georgian Medical Research Clinic Helthycore Ltd
Oct 12, 2022

Sinusitis inSingle-center Prospective Cohort of Exudative AMD

Recruiting
  • AMD
  • sinusitis screening consultation
  • Paris, France
    Hôpital Fondation A. de Rothschild
Jan 23, 2023

Stroke Trial in Basel (Non-contrast cranial MDCT head scan, Non-contrast syngo DynaCT Sine Spin head scan and application

Not yet recruiting
  • Stroke
  • Non-contrast cranial MDCT head scan
  • Non-contrast syngo DynaCT Sine Spin head scan and application software
  • Basel, Switzerland
    University Hospital Basel
Jul 19, 2022

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Pain Perception, Secondary Hyperalgesia Trial in Basel (Study Intervention: 25 ms half-sine wave stimulation, Control

Recruiting
  • Pain Perception
  • Secondary Hyperalgesia
  • Study Intervention: 25 ms half-sine wave stimulation
  • Control Intervention: 500 µs rectangular shaped stimulation
  • Basel, Switzerland
    Department of Anaesthesiology, University Hospital of Basel (USB
Jun 28, 2022

Colorectal Adenomas Trial in Xi'an (100mg Berberine HCl, 300mg Berberine HCl, Placebo Oral Tablet)

Completed
  • Colorectal Adenomas
  • 100mg Berberine hydrochloride
  • +2 more
  • Xi'an, Shaanxi, China
    Li
Jul 24, 2022

MDS Trial in New York (selinexor (KPT-330))

Completed
Has Results
  • Myelodysplastic Syndromes
  • selinexor (KPT-330)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 11, 2022

Overweight and Obesity, Weight Loss, Pregnancy Related Trial in Aarhus (Weight loss intervention)

Not yet recruiting
  • Overweight and Obesity
  • +4 more
  • Weight loss intervention
  • Aarhus, Denmark
    Aarhus University Hospital
Mar 23, 2023

Colorectal Adenomas Trial in Xi'an (Berberine HCl, Placebo)

Completed
  • Colorectal Adenomas
  • Berberine hydrochloride
  • Placebo
  • Xi'an, Shaanxi, China
    Xijing Hospital of Digestive Disease
Jul 24, 2022

Dry Eye Syndromes Trial in Vienna (Prosicca, Prosicca sine, Bacterial culture)

Recruiting
  • Dry Eye Syndromes
  • Vienna, Austria
  • +1 more
Apr 6, 2022

Refractory Multiple Myeloma Trial in United States (selinexor, carfilzomib, dexamethasone)

Recruiting
  • Refractory Multiple Myeloma
  • Scottsdale, Arizona
  • +4 more
Apr 1, 2022

Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

Completed
  • Leukemia
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Suspended
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +4 more
  • Detroit, Michigan
  • +1 more
Feb 2, 2022

Lipid Based Eye Drops on Tear Film Lipid Layer Thickness

Recruiting
  • Dry Eye Syndromes
  • Cationorm MD sine eye drops
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Apr 6, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting
  • Advanced Alveolar Soft Part Sarcoma
  • +3 more
  • Atezolizumab
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jan 28, 2023

Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jun 28, 2022

Dyspnea, Malignant Tumor Trial in Houston (Dexamethasone, Placebo, Questionnaire Administration)

Active, not recruiting
Has Results
  • Dyspnea
  • Malignant Neoplasm
  • Houston, Texas
  • +2 more
Nov 29, 2022

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Advanced Malignant Tumor, Cancer Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023